Pfizer Inc. (NYSE:PFE) is one of the Best Growth Stocks Under $25 to Buy Right Now. On October 14, Pfizer Inc. (NYSE:PFE) ...

He stipulated that the honoree should be a force for good, and selected Pfizer Chairman Albert Bourla for his innovation, ...

Pfizer has agreed to acquire Metsera, a company specializing in weight-loss medications, for $47.50 per share in cash, along ...

Pfizer's stock price is down materially from its 2021 highs, but it is also up notably from its April 2025 lows.

Pfizer is backed by strong H1 results, a promising pipeline, improved financials, and solid valuation with long-term growth ...

One Louisiana woman, Robin Phillip, said she developed an intracranial meningioma that caused her to lose vision in her left ...

But this research team found its results so promising that it is preparing a more rigorous study to see if mRNA coronavirus ...

With the administration’s aggressive tactics, pharmaceutical companies cannot avoid this reckoning, but they can shape how it ...

The pharmaceutical giant has granted the president’s long-standing demands. Other drug companies could be next.

Pfizer Chief Executive Albert Bourla said on Tuesday that the U.S. pharmaceutical industry needs to collaborate with China’s, ...

() -Pfizer and Japanese firm Astellas' drug Padcev, combined with Merck's Keytruda, lowered the risk of tumor recurrence, ...

If approved alongside current SoC maintenance therapies, Tukysa could become the first update to the regimen for ...